nodes	percent_of_prediction	percent_of_DWPC	metapath
Amifostine—ALPPL2—forelimb zeugopod—muscle cancer	0.234	0.324	CbGeAlD
Amifostine—ALPPL2—hindlimb—muscle cancer	0.106	0.147	CbGeAlD
Amifostine—ALPPL2—arm—muscle cancer	0.101	0.14	CbGeAlD
Amifostine—ALPPL2—appendage—muscle cancer	0.0909	0.126	CbGeAlD
Amifostine—ALPPL2—embryo—muscle cancer	0.0302	0.0418	CbGeAlD
Amifostine—ALPL—BDNF signaling pathway—KIDINS220—muscle cancer	0.0257	0.149	CbGpPWpGaD
Amifostine—ENPP1—renal system—muscle cancer	0.0237	0.0328	CbGeAlD
Amifostine—ALPPL2—renal system—muscle cancer	0.0228	0.0316	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—PTCH1—muscle cancer	0.0194	0.112	CbGpPWpGaD
Amifostine—ENPP1—tendon—muscle cancer	0.0185	0.0256	CbGeAlD
Amifostine—ALPPL2—bone marrow—muscle cancer	0.0173	0.0239	CbGeAlD
Amifostine—ALPL—testis—muscle cancer	0.0167	0.0231	CbGeAlD
Amifostine—ENPP1—Endochondral Ossification—PTCH1—muscle cancer	0.0165	0.0955	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—FOXO4—muscle cancer	0.0162	0.0942	CbGpPWpGaD
Amifostine—ALPL—NOTCH1 regulation of human endothelial cell calcification—VEGFA—muscle cancer	0.0162	0.0938	CbGpPWpGaD
Amifostine—ENPP1—head—muscle cancer	0.0159	0.0219	CbGeAlD
Amifostine—ENPP1—testis—muscle cancer	0.0153	0.0212	CbGeAlD
Amifostine—ALPPL2—head—muscle cancer	0.0153	0.0211	CbGeAlD
Amifostine—ALPPL2—testis—muscle cancer	0.0148	0.0204	CbGeAlD
Amifostine—ALPL—Endochondral Ossification—IGF2—muscle cancer	0.0134	0.0775	CbGpPWpGaD
Amifostine—ALPL—AGE/RAGE pathway—FOXO1—muscle cancer	0.012	0.0696	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—IGF2—muscle cancer	0.0114	0.0659	CbGpPWpGaD
Amifostine—ALPL—BDNF signaling pathway—CNR1—muscle cancer	0.00854	0.0495	CbGpPWpGaD
Amifostine—ALPL—Endochondral Ossification—VEGFA—muscle cancer	0.0056	0.0325	CbGpPWpGaD
Amifostine—ENPP1—Insulin Signaling—FOXO1—muscle cancer	0.00502	0.0291	CbGpPWpGaD
Amifostine—ENPP1—Endochondral Ossification—VEGFA—muscle cancer	0.00476	0.0276	CbGpPWpGaD
Amifostine—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—muscle cancer	0.00473	0.0274	CbGpPWpGaD
Amifostine—Hypocalcaemia—Dactinomycin—muscle cancer	0.00336	0.032	CcSEcCtD
Amifostine—Rigors—Etoposide—muscle cancer	0.00272	0.026	CcSEcCtD
Amifostine—Apnoea—Etoposide—muscle cancer	0.00262	0.025	CcSEcCtD
Amifostine—ENPP1—Metabolism—FH—muscle cancer	0.00261	0.0152	CbGpPWpGaD
Amifostine—Chest discomfort—Etoposide—muscle cancer	0.00251	0.024	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Dactinomycin—muscle cancer	0.00201	0.0191	CcSEcCtD
Amifostine—Cardiac arrest—Vincristine—muscle cancer	0.00189	0.0181	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Dactinomycin—muscle cancer	0.0017	0.0162	CcSEcCtD
Amifostine—Anaphylactoid reaction—Etoposide—muscle cancer	0.00167	0.0159	CcSEcCtD
Amifostine—ENPP1—Disease—ENO2—muscle cancer	0.00161	0.00932	CbGpPWpGaD
Amifostine—Apnoea—Methotrexate—muscle cancer	0.00157	0.015	CcSEcCtD
Amifostine—Cardiac arrest—Etoposide—muscle cancer	0.00153	0.0146	CcSEcCtD
Amifostine—Acute coronary syndrome—Vincristine—muscle cancer	0.00151	0.0144	CcSEcCtD
Amifostine—Myocardial infarction—Vincristine—muscle cancer	0.00151	0.0143	CcSEcCtD
Amifostine—ENPP1—Metabolism—MED12—muscle cancer	0.00148	0.00856	CbGpPWpGaD
Amifostine—Feeling hot—Doxorubicin—muscle cancer	0.00147	0.014	CcSEcCtD
Amifostine—ENPP1—Disease—HMGA1—muscle cancer	0.00146	0.00847	CbGpPWpGaD
Amifostine—Erythema multiforme—Dactinomycin—muscle cancer	0.00146	0.0139	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Etoposide—muscle cancer	0.00145	0.0139	CcSEcCtD
Amifostine—Flushing—Dactinomycin—muscle cancer	0.00143	0.0136	CcSEcCtD
Amifostine—Rigors—Doxorubicin—muscle cancer	0.00141	0.0135	CcSEcCtD
Amifostine—Chills—Dactinomycin—muscle cancer	0.00138	0.0132	CcSEcCtD
Amifostine—ENPP1—Metabolism—ENO2—muscle cancer	0.00135	0.00781	CbGpPWpGaD
Amifostine—ENPP1—Disease—FOXO4—muscle cancer	0.00131	0.0076	CbGpPWpGaD
Amifostine—Hypocalcaemia—Doxorubicin—muscle cancer	0.00126	0.012	CcSEcCtD
Amifostine—Ill-defined disorder—Dactinomycin—muscle cancer	0.00125	0.0119	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Etoposide—muscle cancer	0.00123	0.0118	CcSEcCtD
Amifostine—Acute coronary syndrome—Etoposide—muscle cancer	0.00123	0.0117	CcSEcCtD
Amifostine—Renal failure—Etoposide—muscle cancer	0.00122	0.0117	CcSEcCtD
Amifostine—Myocardial infarction—Etoposide—muscle cancer	0.00122	0.0116	CcSEcCtD
Amifostine—Malaise—Dactinomycin—muscle cancer	0.00121	0.0115	CcSEcCtD
Amifostine—Hiccups—Doxorubicin—muscle cancer	0.00115	0.011	CcSEcCtD
Amifostine—Discomfort—Dactinomycin—muscle cancer	0.00113	0.0108	CcSEcCtD
Amifostine—Erythema multiforme—Etoposide—muscle cancer	0.00106	0.0101	CcSEcCtD
Amifostine—Convulsion—Vincristine—muscle cancer	0.00104	0.00991	CcSEcCtD
Amifostine—Flushing—Etoposide—muscle cancer	0.00104	0.00988	CcSEcCtD
Amifostine—Hypertension—Vincristine—muscle cancer	0.00104	0.00987	CcSEcCtD
Amifostine—Dermatitis exfoliative—Methotrexate—muscle cancer	0.00102	0.00977	CcSEcCtD
Amifostine—Chills—Etoposide—muscle cancer	0.001	0.00955	CcSEcCtD
Amifostine—Anaphylactoid reaction—Methotrexate—muscle cancer	0.000999	0.00952	CcSEcCtD
Amifostine—Anaphylactic shock—Vincristine—muscle cancer	0.000979	0.00933	CcSEcCtD
Amifostine—ENPP1—Disease—FOXO1—muscle cancer	0.000968	0.00561	CbGpPWpGaD
Amifostine—Hypotension—Vincristine—muscle cancer	0.000915	0.00872	CcSEcCtD
Amifostine—Feeling abnormal—Dactinomycin—muscle cancer	0.000903	0.00861	CcSEcCtD
Amifostine—Ill-defined disorder—Etoposide—muscle cancer	0.000902	0.0086	CcSEcCtD
Amifostine—Dermatitis exfoliative—Doxorubicin—muscle cancer	0.000887	0.00846	CcSEcCtD
Amifostine—Malaise—Etoposide—muscle cancer	0.000877	0.00835	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Methotrexate—muscle cancer	0.000871	0.0083	CcSEcCtD
Amifostine—Body temperature increased—Dactinomycin—muscle cancer	0.000867	0.00826	CcSEcCtD
Amifostine—Anaphylactoid reaction—Doxorubicin—muscle cancer	0.000865	0.00824	CcSEcCtD
Amifostine—Loss of consciousness—Etoposide—muscle cancer	0.000854	0.00814	CcSEcCtD
Amifostine—Convulsion—Etoposide—muscle cancer	0.000842	0.00803	CcSEcCtD
Amifostine—Hypertension—Etoposide—muscle cancer	0.000839	0.008	CcSEcCtD
Amifostine—Chest pain—Etoposide—muscle cancer	0.000828	0.00789	CcSEcCtD
Amifostine—Discomfort—Etoposide—muscle cancer	0.000818	0.00779	CcSEcCtD
Amifostine—Hypersensitivity—Dactinomycin—muscle cancer	0.000808	0.0077	CcSEcCtD
Amifostine—Cardiac arrest—Doxorubicin—muscle cancer	0.000796	0.00759	CcSEcCtD
Amifostine—Anaphylactic shock—Etoposide—muscle cancer	0.000793	0.00756	CcSEcCtD
Amifostine—Tachycardia—Etoposide—muscle cancer	0.000774	0.00738	CcSEcCtD
Amifostine—Body temperature increased—Vincristine—muscle cancer	0.000774	0.00738	CcSEcCtD
Amifostine—Toxic epidermal necrolysis—Doxorubicin—muscle cancer	0.000754	0.00719	CcSEcCtD
Amifostine—Hypotension—Etoposide—muscle cancer	0.000741	0.00707	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.000739	0.00704	CcSEcCtD
Amifostine—ENPP1—Disease—KIT—muscle cancer	0.000738	0.00428	CbGpPWpGaD
Amifostine—Renal failure—Methotrexate—muscle cancer	0.000732	0.00698	CcSEcCtD
Amifostine—Hypersensitivity—Vincristine—muscle cancer	0.000722	0.00688	CcSEcCtD
Amifostine—Dyspnoea—Etoposide—muscle cancer	0.000707	0.00674	CcSEcCtD
Amifostine—Somnolence—Etoposide—muscle cancer	0.000705	0.00672	CcSEcCtD
Amifostine—Vomiting—Dactinomycin—muscle cancer	0.000697	0.00664	CcSEcCtD
Amifostine—Rash—Dactinomycin—muscle cancer	0.000691	0.00659	CcSEcCtD
Amifostine—Feeling abnormal—Etoposide—muscle cancer	0.000654	0.00623	CcSEcCtD
Amifostine—Nausea—Dactinomycin—muscle cancer	0.000651	0.00621	CcSEcCtD
Amifostine—Dizziness—Vincristine—muscle cancer	0.000648	0.00617	CcSEcCtD
Amifostine—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00064	0.0061	CcSEcCtD
Amifostine—Renal failure—Doxorubicin—muscle cancer	0.000634	0.00604	CcSEcCtD
Amifostine—Erythema multiforme—Methotrexate—muscle cancer	0.000632	0.00603	CcSEcCtD
Amifostine—Urticaria—Etoposide—muscle cancer	0.00063	0.00601	CcSEcCtD
Amifostine—Body temperature increased—Etoposide—muscle cancer	0.000627	0.00598	CcSEcCtD
Amifostine—Vomiting—Vincristine—muscle cancer	0.000623	0.00593	CcSEcCtD
Amifostine—Rash—Vincristine—muscle cancer	0.000618	0.00589	CcSEcCtD
Amifostine—Dermatitis—Vincristine—muscle cancer	0.000617	0.00588	CcSEcCtD
Amifostine—Chills—Methotrexate—muscle cancer	0.0006	0.00572	CcSEcCtD
Amifostine—Bradycardia—Doxorubicin—muscle cancer	0.00059	0.00562	CcSEcCtD
Amifostine—Hypersensitivity—Etoposide—muscle cancer	0.000585	0.00557	CcSEcCtD
Amifostine—Nausea—Vincristine—muscle cancer	0.000582	0.00554	CcSEcCtD
Amifostine—ENPP1—Disease—MDM2—muscle cancer	0.000581	0.00337	CbGpPWpGaD
Amifostine—Pruritus—Etoposide—muscle cancer	0.000561	0.00535	CcSEcCtD
Amifostine—ENPP1—Disease—PTGS2—muscle cancer	0.00056	0.00325	CbGpPWpGaD
Amifostine—Erythema multiforme—Doxorubicin—muscle cancer	0.000548	0.00522	CcSEcCtD
Amifostine—Ill-defined disorder—Methotrexate—muscle cancer	0.00054	0.00515	CcSEcCtD
Amifostine—Flushing—Doxorubicin—muscle cancer	0.000538	0.00512	CcSEcCtD
Amifostine—Malaise—Methotrexate—muscle cancer	0.000525	0.005	CcSEcCtD
Amifostine—Dizziness—Etoposide—muscle cancer	0.000525	0.005	CcSEcCtD
Amifostine—Chills—Doxorubicin—muscle cancer	0.00052	0.00495	CcSEcCtD
Amifostine—Arrhythmia—Doxorubicin—muscle cancer	0.000517	0.00493	CcSEcCtD
Amifostine—Convulsion—Methotrexate—muscle cancer	0.000505	0.00481	CcSEcCtD
Amifostine—Vomiting—Etoposide—muscle cancer	0.000504	0.00481	CcSEcCtD
Amifostine—Rash—Etoposide—muscle cancer	0.0005	0.00477	CcSEcCtD
Amifostine—Dermatitis—Etoposide—muscle cancer	0.0005	0.00476	CcSEcCtD
Amifostine—Chest pain—Methotrexate—muscle cancer	0.000496	0.00472	CcSEcCtD
Amifostine—Discomfort—Methotrexate—muscle cancer	0.00049	0.00467	CcSEcCtD
Amifostine—Anaphylactic shock—Methotrexate—muscle cancer	0.000475	0.00453	CcSEcCtD
Amifostine—Nausea—Etoposide—muscle cancer	0.000471	0.00449	CcSEcCtD
Amifostine—ENPP1—Metabolism—PTGS2—muscle cancer	0.000469	0.00272	CbGpPWpGaD
Amifostine—Ill-defined disorder—Doxorubicin—muscle cancer	0.000468	0.00446	CcSEcCtD
Amifostine—Malaise—Doxorubicin—muscle cancer	0.000455	0.00433	CcSEcCtD
Amifostine—Syncope—Doxorubicin—muscle cancer	0.000452	0.00431	CcSEcCtD
Amifostine—Hypotension—Methotrexate—muscle cancer	0.000444	0.00423	CcSEcCtD
Amifostine—Loss of consciousness—Doxorubicin—muscle cancer	0.000443	0.00422	CcSEcCtD
Amifostine—Convulsion—Doxorubicin—muscle cancer	0.000437	0.00416	CcSEcCtD
Amifostine—Hypertension—Doxorubicin—muscle cancer	0.000435	0.00415	CcSEcCtD
Amifostine—Chest pain—Doxorubicin—muscle cancer	0.000429	0.00409	CcSEcCtD
Amifostine—Discomfort—Doxorubicin—muscle cancer	0.000424	0.00404	CcSEcCtD
Amifostine—Dyspnoea—Methotrexate—muscle cancer	0.000424	0.00404	CcSEcCtD
Amifostine—Somnolence—Methotrexate—muscle cancer	0.000422	0.00403	CcSEcCtD
Amifostine—Anaphylactic shock—Doxorubicin—muscle cancer	0.000412	0.00392	CcSEcCtD
Amifostine—Shock—Doxorubicin—muscle cancer	0.000405	0.00386	CcSEcCtD
Amifostine—Tachycardia—Doxorubicin—muscle cancer	0.000402	0.00383	CcSEcCtD
Amifostine—Feeling abnormal—Methotrexate—muscle cancer	0.000392	0.00373	CcSEcCtD
Amifostine—Hypotension—Doxorubicin—muscle cancer	0.000385	0.00366	CcSEcCtD
Amifostine—Urticaria—Methotrexate—muscle cancer	0.000378	0.0036	CcSEcCtD
Amifostine—Body temperature increased—Methotrexate—muscle cancer	0.000376	0.00358	CcSEcCtD
Amifostine—Dyspnoea—Doxorubicin—muscle cancer	0.000367	0.0035	CcSEcCtD
Amifostine—Somnolence—Doxorubicin—muscle cancer	0.000366	0.00349	CcSEcCtD
Amifostine—Hypersensitivity—Methotrexate—muscle cancer	0.00035	0.00334	CcSEcCtD
Amifostine—Feeling abnormal—Doxorubicin—muscle cancer	0.000339	0.00323	CcSEcCtD
Amifostine—Pruritus—Methotrexate—muscle cancer	0.000336	0.0032	CcSEcCtD
Amifostine—Urticaria—Doxorubicin—muscle cancer	0.000327	0.00312	CcSEcCtD
Amifostine—Body temperature increased—Doxorubicin—muscle cancer	0.000325	0.0031	CcSEcCtD
Amifostine—Dizziness—Methotrexate—muscle cancer	0.000314	0.00299	CcSEcCtD
Amifostine—Hypersensitivity—Doxorubicin—muscle cancer	0.000303	0.00289	CcSEcCtD
Amifostine—Vomiting—Methotrexate—muscle cancer	0.000302	0.00288	CcSEcCtD
Amifostine—Rash—Methotrexate—muscle cancer	0.0003	0.00286	CcSEcCtD
Amifostine—Dermatitis—Methotrexate—muscle cancer	0.000299	0.00285	CcSEcCtD
Amifostine—Pruritus—Doxorubicin—muscle cancer	0.000291	0.00277	CcSEcCtD
Amifostine—Nausea—Methotrexate—muscle cancer	0.000282	0.00269	CcSEcCtD
Amifostine—Dizziness—Doxorubicin—muscle cancer	0.000272	0.00259	CcSEcCtD
Amifostine—Vomiting—Doxorubicin—muscle cancer	0.000262	0.00249	CcSEcCtD
Amifostine—Rash—Doxorubicin—muscle cancer	0.000259	0.00247	CcSEcCtD
Amifostine—Dermatitis—Doxorubicin—muscle cancer	0.000259	0.00247	CcSEcCtD
Amifostine—Nausea—Doxorubicin—muscle cancer	0.000244	0.00233	CcSEcCtD
